Proteios is led by a multidisciplinary team with experience across biomedical research, commercialisation, investment, and governance. The company operates with a lean core team and engages specialist advisers as required.
Director
Successful entrepreneur across multiple industries.
Lead investor in Proteios Therapeutics.
Provides strategic leadership, business development, investor and stakeholder engagement, corporate governance oversight, partnership development, capital raising support, commercial strategy, and coordination of board, advisory, and industry relationships.
Professor of Organic Chemistry and Chemical Biology
Co-inventor of Proteios Therapeutics Technology and Co-Founder
International leader in drug discovery with extensive partnerships with pharma (e.g. Novo Nordisk and AZ). Provides expertise in peptide chemistry.
Interim CEO
Venture Lead, Sydney Biomedical Accelerator Venture Studio
Biotechnology executive with experience translating biomedical innovations from proof-of-concept to clinical development. Leads commercialisation, fundraising, and strategic partnerships.
Professor of Immunology
Co-inventor, Scientific Founder and Adviser
International leader in immuno-dermatopathology with strong links with dermatologists. Provides expertise in inflammatory skin diseases.
ECR Immunologist
Co-inventor and Scientific Advisor
Immunologist that generated much of the preliminary efficacy data and leading implementation of USyd-led in vivo/ex vivo validation of formulations.
Scientific Advisor
A medicinal chemist with 15 years of prior industry experience at Pfizer and UCB. Serves as liaison with Proteios Therapeutics formulation partners.
Governance and Operations Manager
Supports governance, operations, compliance, marketing, stakeholder administration, and business operations.
Commercialisation Support
Provides commercialisation expertise, business development connections and strategic input into pipeline prioritisation.
Head of Dermatology
Westmead Hospital, NSW
Pablo Fernández-Peñas is Professor in Dermatology at Sydney Medical School (The University of Sydney), and Senior Medical Practitioner (Academic) at Westmead Hospital. He was appointed Head of the Department of Dermatology at Westmead Hospital in 2010, and Director of the Centre for Translational Skin Research in 2017. At the Skin and Cancer Foundation Australia, he has been the Head of Education (2011-15) and Head of Research (2008-2018).
As Proteios enters its next phase of development and commercialisation, the company is strengthening its executive leadership, including the appointment of a Chief Executive Officer to lead strategy execution and external engagement.